IL158059A0 - Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives - Google Patents

Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Info

Publication number
IL158059A0
IL158059A0 IL15805902A IL15805902A IL158059A0 IL 158059 A0 IL158059 A0 IL 158059A0 IL 15805902 A IL15805902 A IL 15805902A IL 15805902 A IL15805902 A IL 15805902A IL 158059 A0 IL158059 A0 IL 158059A0
Authority
IL
Israel
Prior art keywords
homoerythromycin
deoxo
aza
derivatives
substituted
Prior art date
Application number
IL15805902A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL158059A0 publication Critical patent/IL158059A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL15805902A 2001-04-27 2002-04-11 Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives IL158059A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28720301P 2001-04-27 2001-04-27
PCT/IB2002/001252 WO2002088158A1 (en) 2001-04-27 2002-04-11 Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (1)

Publication Number Publication Date
IL158059A0 true IL158059A0 (en) 2004-03-28

Family

ID=23101880

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15805902A IL158059A0 (en) 2001-04-27 2002-04-11 Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
IL149226A IL149226A (en) 2001-04-27 2002-04-19 Process for the preparation of derivatives of 9-deoxo-9A -AZA-9A-homoarithromycin A is converted in position 4
IL182418A IL182418A (en) 2001-04-27 2002-04-19 Process for the preparation of derivatives of 9 - deoxo-9A – AZA – A9 - homoarithromycin A is converted in position 4

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL149226A IL149226A (en) 2001-04-27 2002-04-19 Process for the preparation of derivatives of 9-deoxo-9A -AZA-9A-homoarithromycin A is converted in position 4
IL182418A IL182418A (en) 2001-04-27 2002-04-19 Process for the preparation of derivatives of 9 - deoxo-9A – AZA – A9 - homoarithromycin A is converted in position 4

Country Status (23)

Country Link
US (1) US6825327B2 (ru)
EP (2) EP1383780A1 (ru)
JP (3) JP4104463B2 (ru)
KR (1) KR100474225B1 (ru)
CN (4) CN1297564C (ru)
AR (1) AR035871A1 (ru)
AU (1) AU784362B2 (ru)
BR (2) BR0209241A (ru)
CA (2) CA2445306C (ru)
CZ (1) CZ303716B6 (ru)
DK (1) DK1253153T3 (ru)
ES (1) ES2608848T3 (ru)
HK (2) HK1050370A1 (ru)
HU (1) HU230717B1 (ru)
IL (3) IL158059A0 (ru)
MX (2) MXPA03009786A (ru)
PL (2) PL371766A1 (ru)
PT (1) PT1253153T (ru)
RU (2) RU2263117C2 (ru)
SG (1) SG100789A1 (ru)
WO (1) WO2002088158A1 (ru)
YU (1) YU29502A (ru)
ZA (2) ZA200203252B (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82359C2 (ru) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиция (варианты) и способ лечения микробных и паразитарных инфекций у крупного рогатого скота и других животных
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
PE20060693A1 (es) 2004-09-23 2006-09-01 Schering Plough Ltd Nuevos derivados de trifluorometansulfonanilida oxamida eter
EP1811841B1 (en) 2004-11-19 2009-10-28 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
US20080227730A1 (en) * 2005-01-14 2008-09-18 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
US20060281695A1 (en) * 2005-06-09 2006-12-14 Schering-Plough Animal Health Corporation Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
CA2672586A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
BRPI0810929B8 (pt) 2007-06-27 2022-12-06 Du Pont uso de um composto de fórmula 1
TWI468407B (zh) 2008-02-06 2015-01-11 Du Pont 中離子農藥
CN102131772B (zh) * 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
WO2010086351A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
IN2012DN00709A (ru) 2009-08-05 2015-06-19 Du Pont
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
JP2013501063A (ja) 2009-08-05 2013-01-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー メソイオン性殺虫剤
HUE028501T2 (en) 2010-05-27 2016-12-28 Du Pont 4- [5- [3-Chloro-5- (trifluoromethyl) phenyl] -4,5-dihydro-5- (trifluoromethyl) -3-isoxazolyl] -N- [2-oxo-2 - [(2.2, 2-Trifluoroethyl) amino] ethyl] -1-naphthalenecarboxamide crystalline form
WO2012001089A1 (en) * 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions
ES2532455T3 (es) 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) * 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN108473524B (zh) * 2016-01-18 2021-11-02 浙江海正药业股份有限公司 一种泰拉霉素的制备方法及其中间体
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN106434797A (zh) * 2016-08-25 2017-02-22 艾美科健（中国）生物医药有限公司 一种酶法合成泰拉霉素的工艺
CN106939029B (zh) * 2017-04-28 2020-10-13 艾美科健（中国）生物医药有限公司 一种泰拉霉素的制备方法
CN107400152B (zh) * 2017-08-29 2019-10-15 博瑞生物医药（苏州）股份有限公司 泰拉菌素草酸盐
CN107556351B (zh) * 2017-08-29 2019-10-18 博瑞生物医药（苏州）股份有限公司 一种泰拉菌素的制备方法
CN109535210A (zh) * 2018-12-19 2019-03-29 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质e的方法
CN114007625A (zh) 2019-04-18 2022-02-01 阿祖拉眼科有限公司 用于治疗眼病的化合物和方法
CN111072730B (zh) * 2019-12-16 2021-01-12 浙江国邦药业有限公司 一种泰拉霉素中间体盐的制备方法及应用
CN112225769A (zh) * 2020-09-21 2021-01-15 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质e的方法
CN113493483A (zh) * 2021-07-05 2021-10-12 上海应用技术大学 一种泰拉霉素的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4518590A (en) 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
EP0549040A1 (en) 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (ru) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членные азалиды и их применение как антибиотиков
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum

Also Published As

Publication number Publication date
BR0201437A (pt) 2003-06-10
KR20020083474A (ko) 2002-11-02
EP1253153A1 (en) 2002-10-30
CN100413879C (zh) 2008-08-27
CA2445306C (en) 2008-02-12
KR100474225B1 (ko) 2005-03-08
CN1295240C (zh) 2007-01-17
AR035871A1 (es) 2004-07-21
CN1384108A (zh) 2002-12-11
CZ303716B6 (cs) 2013-04-03
HU0201385D0 (ru) 2002-06-29
CN1530370A (zh) 2004-09-22
HK1065803A1 (en) 2005-03-04
US6825327B2 (en) 2004-11-30
RU2233287C2 (ru) 2004-07-27
CA2383409A1 (en) 2002-10-27
CN1167708C (zh) 2004-09-22
SG100789A1 (en) 2003-12-26
PL353633A1 (en) 2002-11-04
AU784362B2 (en) 2006-03-16
IL149226A0 (en) 2002-11-10
ES2608848T3 (es) 2017-04-17
RU2263117C2 (ru) 2005-10-27
BRPI0201437B1 (pt) 2017-11-28
ZA200307506B (en) 2005-01-26
PL213731B1 (pl) 2013-04-30
JP2004528353A (ja) 2004-09-16
IL182418A0 (en) 2008-01-06
HK1050370A1 (en) 2003-06-20
EP1383780A1 (en) 2004-01-28
HU230717B1 (hu) 2017-11-28
HUP0201385A2 (hu) 2003-12-29
JP2002326998A (ja) 2002-11-15
ZA200203252B (en) 2003-10-24
PL371766A1 (en) 2005-06-27
MXPA03009786A (es) 2004-01-29
CN1297564C (zh) 2007-01-31
CN1503804A (zh) 2004-06-09
BR0209241A (pt) 2004-06-15
CZ20021417A3 (cs) 2003-05-14
IL149226A (en) 2008-06-05
JP4100955B2 (ja) 2008-06-11
YU29502A (sh) 2005-03-15
CN1715289A (zh) 2006-01-04
DK1253153T3 (da) 2017-01-02
IL182418A (en) 2012-07-31
MXPA02004231A (es) 2002-11-13
JP2007091754A (ja) 2007-04-12
BRPI0201437B8 (pt) 2021-05-25
AU3563002A (en) 2002-10-31
CA2383409C (en) 2007-01-02
EP1253153B1 (en) 2016-11-02
JP4104463B2 (ja) 2008-06-18
WO2002088158A1 (en) 2002-11-07
RU2003131351A (ru) 2005-02-27
CA2445306A1 (en) 2002-11-07
PT1253153T (pt) 2016-12-29
US20030064939A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
IL158059A0 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
IL209827A0 (en) A process for preparing pyrazole derivatives
IL140079A0 (en) Process for producing bisphennol a
HUP0402027A3 (en) Process for the preparation of a xantophyll
IL189161A0 (en) A process for the preparing a 2-nitro-2'-carboxy-diphenylsulfide derivative
PL352291A1 (en) Process for making a pipa-polyol
HK1063803A1 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
GB0125191D0 (en) Process for preparing imadacloprid
SI1047666T1 (en) Process for preparing a ketimine
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
GB2350611B (en) Process for producing a diarylamine
HUP0204145A3 (en) Process for preparing a quinolylacrylonitrile derivative and its intermediate and the novel intermediate
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
PL361225A1 (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin a derivatives from 9-deoxo-9(z)-hydroxyiminoerythromycin a
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
HK1087414A1 (en) Process for preparing 4"-substituted-9-deoxo-9A-aza-9A-homoerythromycin a derivatives
IL146810A0 (en) Process for preparing 10, 11-methanobenzosuberane derivatives
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
HUP0300259A3 (en) Process for preparing 5'-acetylstavudine
EP1451178A4 (en) PROCESS FOR PREPARING BEAT D RIBOFURANOSE DERIVATIVES
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
HUP0204443A3 (en) Process for preparing fluoroformates